The Sidney Kimmel Cancer Center – Jefferson Health announced a collaboration with Driver, a first-of-its-kind global technology platform that connects cancer patients to the best treatments, which has launched in the United States and China.
Driver’s platform enables any patient, anywhere in the world, to access treatment options across an unprecedented network of cancer centers without leaving home.
NCI and the Chinese National Cancer Center are the founding members of Driver’s global network. To date, more than thirty leading cancer centers in addition to SKCC comprise Driver’s network, including the Cleveland Clinic; Mayo Clinic; Massachusetts General Hospital; University of California, San Francisco; University of California, Los Angeles; Duke University; University of North Carolina; and Emory.
In order to provide patients with extensive cancer treatment options and information, Driver processes medical records and tumor data, then offers current evidence-based treatment guidelines as well as information on clinical trials for which a patient is potentially eligible that are being offered at any of the cancer centers in Driver’s network.
Driver’s lead investor is Horizons Ventures, with whom Driver has partnered from its inception to build its platform in China in parallel to the United States.
